P-glycoprotein inhibition by the agricultural pesticide propiconazole and its hydroxylated metabolites: Implications for pesticide–drug interactions
- 1 January 2015
- journal article
- Published by Elsevier in Toxicology Letters
- Vol. 232 (1) , 37-45
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Human and Rat ABC Transporter Efflux of Bisphenol A and Bisphenol A Glucuronide: Interspecies Comparison and Implications for Pharmacokinetic AssessmentToxicological Sciences, 2012
- Differences between the non-steroidal aromatase inhibitors anastrozole and letrozole – of clinical importance?British Journal of Cancer, 2011
- Endoxifen, the Active Metabolite of Tamoxifen, Is a Substrate of the Efflux Transporter P-Glycoprotein (Multidrug Resistance 1)Drug Metabolism and Disposition, 2011
- The emerging role of P-glycoprotein inhibitors in drug delivery: a patent reviewExpert Opinion on Therapeutic Patents, 2011
- Endocrine disrupting effects in vitro of conazole antifungals used as pesticides and pharmaceuticalsReproductive Toxicology, 2010
- Role of P-Glycoprotein in the Disposition of Macrocyclic Lactones: A Comparison between Ivermectin, Eprinomectin, and Moxidectin in MiceDrug Metabolism and Disposition, 2010
- Membrane transporters in drug developmentNature Reviews Drug Discovery, 2010
- Role of P-Glycoprotein Inhibition for Drug InteractionsClinical Pharmacokinetics, 2007
- Pesticides and their binary combinations as P-glycoprotein inhibitors in NIH 3T3/MDR1 cellsEnvironmental Toxicology and Pharmacology, 2006
- Interaction of structurally diverse pesticides with thehuman MDR1 gene product P-glycoproteinToxicology and Applied Pharmacology, 1996